UBS O'Connor’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

UBS O'Connor’s Portfolio NFH Stock Details NFH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-716,265	Closed	-$8.21M	–	1225
2021 Q4	$8.21M	Hold	716,265	–	–	0.08%	95
2021 Q3	$8.04M	Hold	716,265	–	–	0.06%	139
2021 Q2	$8M	Hold	716,265	–	–	0.07%	135
2021 Q1	$8.09M	Sell	716,265 -401,396	-36%	-$4.08M	0.12%	113
2020 Q4	$9.61M	Sell	1,117,661 -273,026	-20%	-$2.36M	0.2%	82
2020 Q3	$10.6M	Sell	1,390,687 -62,509	-4%	-$513K	0.27%	55
2020 Q2	$12M	Sell	1,453,196 -26,894	-2%	-$218K	0.27%	93
2020 Q1	$12.2M	Buy	+1,480,090	New	+$13.5M	0.25%	88
2019 Q4	–	Sell	-2,092,510	Closed	-$21.3M	–	384
2019 Q3	$21.3M	Buy	+2,092,510	New	+$21.3M	0.59%	33

Other funds holding NFH

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

UBS O'Connor's NFH Position: Q1 2022 in Review

UBS O'Connor sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q1 2022, closing a stake of 716,265 shares — an estimated $8.21M sold.

UBS O'Connor first reported a position in NFH in Q3 2019 and held it in 9 quarters. The position peaked at $21.3M in Q3 2019. 2 funds tracked by Wall St. Rank hold NFH as of Q1 2022.

UBS O'Connor reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q1 2022 after selling out during the quarter.
UBS O'Connor sold 716,265 New Frontier Health Corporation Ordinary Shares shares in Q1 2022, an estimated $8.21M.
UBS O'Connor first reported a position in New Frontier Health Corporation Ordinary Shares in Q3 2019 and held it in 9 quarters.
UBS O'Connor's New Frontier Health Corporation Ordinary Shares position peaked at $21.3M in Q3 2019.
2 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.